Inventor
KANE JR JOHN L
US11 patents
Patents
11 patentsUS9611265B2Apr 4, 2017
Tropomyosin-related kinase (TRK) inhibitors
GENZYME CORP11 citations91
US9174986B2Nov 3, 2015
Tropomyosin-related kinase (Trk) inhibitors
GENZYME CORP13 citations91
US9067914B1Jun 30, 2015
Tropomyosin-related kinase (TRK) inhibitors
GENZYME CORP15 citations91
US11878024B2Jan 23, 2024
Tropomyosin-related kinase (Trk) inhibitors
GENZYME CORP3 citations84
US11406644B2Aug 9, 2022
Tropomyosin-related kinase (TRK) inhibitors
GENZYME CORP5 citations83
US10166239B2Jan 1, 2019
Tropomyosin-related kinase (Trk) inhibitors
GENZYME CORP9 citations83
US12318392B2Jun 3, 2025
Tropomyosin-related kinase (trk) inhibitors
GENZYME CORP1 citations73
US11274108B2Mar 15, 2022
Colony stimulating factor-1 receptor (CSF-1R) inhibitors
GENZYME CORP2 citations70
US12503477B2Dec 23, 2025
Colony stimulating factor-1 receptor (CSF-1R) inhibitors
GENZYME CORP0 citations59
US11530216B2Dec 20, 2022
Deuterated colony stimulating factor-1 receptor (CSF-1R) inhibitors
GENZYME CORP1 citations49
US7541466B2Jun 2, 2009
Tetrahydroisoquinoline derivatives for treating protein trafficking diseases
GENZYME CORP1 citations42